Rosenberg Aaron
Chief Financial Officer
Rosenberg Aaron has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Aug 5, 2026.
On the most recent filing, Rosenberg Aaron is listed as Chief Financial Officer at BeOne Medicines Ltd. Inside the rolling window, Rosenberg Aaron reported no open-market purchases and 2 open-market sales totaling $524K in ONC. The largest disclosed transaction in the window is a sale of 1,157 ONC shares on Aug 3, 2026, worth $362K.
Companies traded
Other insiders at ONC
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$524K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Rosenberg Aaron made?
Rosenberg Aaron has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does Rosenberg Aaron trade?
Rosenberg Aaron has filed SEC Form 4 disclosures for 1 company, including ONC.
When was Rosenberg Aaron's most recent SEC Form 4 filing?
Rosenberg Aaron's most recent SEC Form 4 filing on Tracefour is dated Aug 5, 2026.
What is Rosenberg Aaron's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Rosenberg Aaron is listed as Chief Financial Officer.
What is Rosenberg Aaron's total buy and sell value in the current window?
Inside the rolling retention window, Rosenberg Aaron bought $0 and sold $524K based on SEC Form 4 filings.
What was Rosenberg Aaron's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,157 ONC shares on 2026-08-03, worth $362K, per SEC Form 4 filings.